focus -WSS

focus

author：explore 2025-09-02 05:49:45 - browse：86

Katie Palmer, STAT (left) moderating the Doctor vs. ChatGPT session during the 2023 STAT Summit. STAT

Generative AI tools are already helping doctors transcribe visits and summarize patient records. The technology behind ChatGPT, trained on vast amounts of data from the internet, made headlines when it correctly answered more than 80% of board exam questions. In July, a team at Beth Israel saw promising results when using GPT-4 during a diagnosis workshop for medical residents.

But the tool is by no means ready for primetime. When given questions about real-life medical scenarios by Stanford researchers, GPT frequently disagreed with humans or offered irrelevant information. The AI models are prone to “hallucinating,” or making things up because they sound right — a tendency that could cause immeasurable harm if let loose on patients. AI leaders and policymakers alike have called for more regulations.

STAT decided to put ChatGPT to the test at its annual summit on Wednesday, pitting the tool against Ann Woolley, infectious disease specialist at Brigham and Women’s Hospital. Marc Succi, the associate innovation chair at Mass General Brigham, gave two patient scenarios to the tool while Woolley explained her own diagnoses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： 6 surprising facts about sugar

WSS

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Yancopoulos of Regeneron works to expand Dupixent success

Mirador, a new biotech startup, launches with $400 million

Asbestos ban is immediate, but health effects will linger for decades

Researchers tackle phage therapy hurdles for wider adoption

Testing GLP

hotspot

focus

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Asbestos ban is immediate, but health effects will linger for decades

At least 13 dead in Texas as scorching temps continue

Obamacare plans could cover weight loss drugs

DIEP, the 'gold standard' of breast reconstruction, is under threat

Steward Health Care expansion into Malta flopped

BioMarin wins approval for gene therapy to treat hemophilia A

Opioid cravings were reduced by anti

Wildfire smoke exposes gaps in outdoor worker protections

This gene therapy has record $4.25 million price. It's saved children.

focus

Measles policy set amid Florida outbreak alarms vaccine proponents

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Chinese researcher claims birth of first gene

In 'major milestone,' FDA approves first cell therapy for solid tumors

Texas board proposes rules on abortion law emergency exemption

Secretariat’s lessons for human medicine

Wikipedia

explore

entertainment

hotspot